RecruitingNCT06479941

Antibiotic Exposure During Pregnancy Affects Infant Gut Microbiota

Sponsor

Peking University People's Hospital

Enrollment

450 participants

Start Date

Jun 25, 2023

Study Type

OBSERVATIONAL

Conditions

Antibiotics Affecting Newborn Gut Microbiota

Summary

Based on a prospective birth cohort, the investigators will collect biological samples from participants including pregnant women and newborns, to measure the gut microbial diversity and metabolites of newborns. These results systematically evaluate the effects of antibiotic exposure on the structure and function of gut microbiota. The project can reveal the effects of antibiotic exposure on the growth and development of gut microbiota in early life.

Eligibility

Min Age: 1 DayMax Age: 12 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying antibiotic treatment for people with antibiotics affecting newborn gut microbiota. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Day to 12 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERantibiotic treatment

AT: Mother-infant cohort with antibiotic treatment group CS: Mother-infant cohort (Prophylactic antibiotics therapy) ND: Mother-infant cohort (Natural delivery)

Locations(1)

The Peking University People's Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06479941